Clinical Trials Related to Chronic Spontaneous Urticaria

Related studies linked through entity extraction aliases.

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT001 Following Intravenous Administration in Participants With Chronic Spontaneous Urticaria (CSU)

Status: RECRUITING
Phase: PHASE1/PHASE2

A Trial of HRS-3095 in Healthy Volunteers

Status: RECRUITING
Phase: EARLY_PHASE1

Remibrutinib in Real-world Clinical Practice - a Germany Sub-study (REASSERT)

Status: RECRUITING
Phase: N/A

A Clinical Trial of HRS-3095 in Patients With Chronic Spontaneous Urticaria

Status: NOT_YET_RECRUITING
Phase: PHASE2

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults

Status: RECRUITING
Phase: PHASE1

A Real-world Study of Remibrutinib in Chronic Spontaneous Urticaria Patients

Status: RECRUITING
Phase: N/A

Trial of JYB1904 Injection in Adult Patients With Chronic Spontaneous Urticaria.

Status: RECRUITING
Phase: PHASE3

Remibrutinib in Real-world Clinical Practice - a US Sub-study

Status: RECRUITING
Phase: N/A

Remibrutinib in Real-world Clinical Practice

Status: RECRUITING
Phase: N/A

A Study to Describe the Real-world Effectiveness, Safety and Patterns of Use of Dupilumab in Patients With Chronic Spontaneous Urticaria

Status: TERMINATED
Phase: N/A

Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria

Status: ENROLLING_BY_INVITATION
Phase: PHASE3

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single and Multiple Doses of HRS-3095 Oral Administration in Healthy Subjects, as Well as the Effect of HRS-3095 on CYP3A4 Metabolic Enzymes

Status: COMPLETED
Phase: PHASE1

A Study to Learn About Ritlecitinib for the Potential Treatment of Chronic Spontaneous Urticaria in Adults.

Status: RECRUITING
Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple-Ascending Doses of BGB-16673 in Adults With Chronic Spontaneous Urticaria

Status: COMPLETED
Phase: PHASE1

A Study to Compare Digital Disease Monitoring of Patients With csU (Telemedicine to Face-to-Face Visits) in Germany

Status: ACTIVE_NOT_RECRUITING
Phase: N/A

Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2

Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)

Status: COMPLETED
Phase: PHASE2

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HS-10561 Capsule in Healthy Chinese Adults and Patients With Chronic Spontaneous Urticaria.

Status: NOT_YET_RECRUITING
Phase: PHASE1/PHASE2

Ritlecitinib (PF-06651600) in Participants With Chronic Spontaneous Urticaria

Status: WITHDRAWN
Phase: PHASE2

A Study of Single Dose of LP-003 in Healthy Adult Subjects

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1